Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation
J. Torregrosa,F. Ferrer-Marín,M. Lozano,M. J. Moreno,C. Martínez,A. Antón,J. Rivera,V. Vicente
DOI: https://doi.org/10.1111/bjh.13539
2016-03-01
British Journal of Haematology
Abstract:concentrate in the management of severe protein C deficiency – experience from 12 centres. British Journal of Haematology, 164, 414–421. Pai, N., Shetty, S. & Ghosh, K. (2010) Protein C (PROC) gene mutations in two Indian families with purpura fulminans. Annals of Hematology, 89, 835–836. Stenson, P.D., Mort, M., Ball, E.V., Shaw, K., Phillips, A.D. & Cooper, D.N. (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Human Genetics, 133, 1–9. Tait, R.C., Walker, I.D., Reitsma, P.H., Islam, S.I., McCall, F., Poort, S.R., Conkie, J.A. & Bertina, R.M. (1995) Prevalence of protein C deficiency in the healthy population. Thrombosis and Haemostasis, 73, 87–93. Takahashi, T., Shinohara, K., Nawata, R., Wakiyama, M. & Hamasaki, N. (1999) A novel mutation of the protein C gene with a frameshift deletion of 3 base pair (3380AGG) in exon 6 in type 1 deficiency associated with arterial and venous thrombosis. American Journal of Hematology, 62, 260–261.